IBO - Impact BioMedical, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.45 0.0 (1.08%) --- --- --- 0.0 (0.0%) 0.0 (1.1%) 0.0 (0.0%) 0.01 (2.39%)

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.18
Diluted EPS:
-1.18
Basic P/E:
-0.3856
Diluted P/E:
-0.3856
RSI(14) 1m:
0.0
VWAP:
0.46
RVol:

Events

Period Kind Movement Occurred At

Related News